Recent Updates
Recently added Catalysts
CTMX Positive Sentiment Score: 70/100

CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Wednesday, January 8, 2025 1 min read
Key Takeaway: CytomX Therapeutics, known for its work in masked, conditionally activated biologics, will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025. CEO Sean McCarthy will lead the presentation at 1:30 p.m. PT. A live webcast will be available on the company's website, and management will also meet with registered investors.

Market Sentiment Analysis

POSITIVE FACTORS

  • CytomX Therapeutics is a leader in its field.
  • The presentation at a prestigious healthcare conference indicates industry recognition.
  • Management will engage with investors, showcasing transparency and openness.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 1:30 p.m. PT.
A live webcast of the presentation will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.
About CytomX Therapeutics
SVP, Chief Financial Officer
Precision AQ (formerly Stern Investor Relations)
stephanie.ascher@precisionaq.com
Redhouse Communications
teri@redhousecomms.com

Frequently Asked Questions

When will CytomX present at the JP Morgan Healthcare Conference?

CytomX will present on January 15, 2025, at 1:30 p.m. PT.

Who will present for CytomX at the conference?

Sean McCarthy, D.Phil., CEO and chairman, will present.

Where can I watch the CytomX presentation live?

The presentation will be available on CytomX’s website.

Will there be investor meetings during the conference?

Yes, management will hold one-on-one meetings with registered investors.

What is the focus of CytomX Therapeutics?

CytomX specializes in masked, conditionally activated biologics.

Tags: CTMX Viatris Investor Conferences Healthcare CytomX Therapeutics J.P. Morgan Conference healthcare Nasdaq CTMX biologics
Last updated: Jan 8, 2025